Skip to main content

Table 1 General characteristics of study patients (n = 431)

From: Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?

CharacteristicPatients: n (%a)
Gender
 Male220 (51)
 Female211 (49)
Age (years)
 ≤4063 (14.6)
 41–60176 (40.8)
 >60192 (44.5)
 Median (IQR)60 (50–70)
Drugs prescribed per patient
 ≤542 (9.7)
 6–10165 (38.3)
 >10224 (52)
 Median (IQR)11 (8–14)
Hospital stay (days)
 ≤279 (18.3)
 3–4143 (33.2)
 >4209 (48.5)
 Median (IQR)4 (3–6)
Number of comorbidities
 No comorbidities24 (5.6)
 1–2170 (39.4)
 3–4127 (29.4)
 510 (2.3)
Comorbidities
 Hypertension220 (51)
 Diabetes mellitus120 (27.8)
 Stroke120 (27.8)
 Chronic obstructive pulmonary disease37 (8.6)
 Ischemic heart disease36 (8.3)
 Urinary tract infection34 (7.9)
 Tuberculosis25 (5.8)
 Hepatitis24 (5.6)
 Chronic kidney disease20 (4.6)
 Asthma16 (3.7)
 Congestive cardiac failure14 (3.2)
 Post tuberculosis bronchiectasis12 (2.8)
 Malaria10 (2.3)
 Decompensated chronic liver disease10 (2.3)
 Left ventricular failure9 (2.1)
 Miscellaneous167 (38.7)
  1. IQR Interquartile range
  2. aPercentage was calculated out of total number of patients i.e., 431